Wednesday, July 2, 2025
Home Tags MIPS

Tag: MIPS

IDT announces successful manufacture of Australia’s first mRNA COVID-19 vaccine candidate

It took just five months for Victorian scientists and manufacturers to develop Australia's first mRNA COVID-19 vaccine candidate — the country's first ever mRNA medicinal product – allowing...

IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...

Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...

IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate

Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...

Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate

The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...

Industry partnership yields high recognition

The Monash Institute of Pharmaceutical Sciences (MIPS) has received high recognition for the Monash-GSK Australian Center for Innovation and Industrialization Project aimed at developing...
Advertisement

Golden Beach Fencing

Com2 Communications

Power Machinery Australia

Featured Article

Don’t get left behind: Manufacturing’s urgent need for digital transformation

As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.